Ai Chikada, Yoshiki Arakawa, Sayaka Takenouchi, Yoshitaka Narita
{"title":"原发性恶性脑肿瘤的预先护理计划:患者和护理人员的知识、经验和偏好。","authors":"Ai Chikada, Yoshiki Arakawa, Sayaka Takenouchi, Yoshitaka Narita","doi":"10.1093/nop/npaf008","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Advance care planning (ACP) can help patients with primary malignant brain tumors to align treatments with their preferences. However, insights into patients' and caregivers' engagement with ACP remain scarce. This study elaborates on their knowledge, experiences, and preferences concerning ACP.</p><p><strong>Methods: </strong>This was a secondary analysis of data from the \"National Survey on the Needs and Support of Brain Tumor Patients and Caregivers\" in Japan. Responses from 128 patients and 106 caregivers were included. Descriptive statistics, logistic regression, and qualitative analyses of free-text responses were performed.</p><p><strong>Results: </strong>Patients were more willing than caregivers to participate in decisions regarding their treatment (96.8% vs. 82.5%, <i>P</i> < .001). Knowledge about ACP was low in both groups (12.3% of patients and 10.7% of caregivers), but willingness to participate in ACP was high (68.9% of patients and 65.9% of caregivers). Preference to initiate ACP at diagnosis was low in both groups, with caregivers showing a higher preference than patients (29.0% vs. 11.1%). A greater percentage of patients preferred to start ACP at recurrence than caregivers (47.0% vs. 18.3%, <i>P</i> < .0001). Frequent family discussions were significantly associated with actual experiences of ACP (OR = 3.7, 95% CI = 1.6-9.3, <i>P</i> = .0019).</p><p><strong>Conclusions: </strong>The mismatch between respondents' willingness to participate in ACP and their knowledge and experience reveals a need to increase ACP awareness. Differences in ACP preferences between patients and their caregivers may indicate the need for improved communication strategies by healthcare professionals. Further research is needed to understand these differences.</p>","PeriodicalId":19234,"journal":{"name":"Neuro-oncology practice","volume":"12 4","pages":"732-742"},"PeriodicalIF":2.5000,"publicationDate":"2025-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12349760/pdf/","citationCount":"0","resultStr":"{\"title\":\"Advance care planning in primary malignant brain tumors: Knowledge, experiences, and preferences of patients and caregivers.\",\"authors\":\"Ai Chikada, Yoshiki Arakawa, Sayaka Takenouchi, Yoshitaka Narita\",\"doi\":\"10.1093/nop/npaf008\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Advance care planning (ACP) can help patients with primary malignant brain tumors to align treatments with their preferences. However, insights into patients' and caregivers' engagement with ACP remain scarce. This study elaborates on their knowledge, experiences, and preferences concerning ACP.</p><p><strong>Methods: </strong>This was a secondary analysis of data from the \\\"National Survey on the Needs and Support of Brain Tumor Patients and Caregivers\\\" in Japan. Responses from 128 patients and 106 caregivers were included. Descriptive statistics, logistic regression, and qualitative analyses of free-text responses were performed.</p><p><strong>Results: </strong>Patients were more willing than caregivers to participate in decisions regarding their treatment (96.8% vs. 82.5%, <i>P</i> < .001). Knowledge about ACP was low in both groups (12.3% of patients and 10.7% of caregivers), but willingness to participate in ACP was high (68.9% of patients and 65.9% of caregivers). Preference to initiate ACP at diagnosis was low in both groups, with caregivers showing a higher preference than patients (29.0% vs. 11.1%). A greater percentage of patients preferred to start ACP at recurrence than caregivers (47.0% vs. 18.3%, <i>P</i> < .0001). Frequent family discussions were significantly associated with actual experiences of ACP (OR = 3.7, 95% CI = 1.6-9.3, <i>P</i> = .0019).</p><p><strong>Conclusions: </strong>The mismatch between respondents' willingness to participate in ACP and their knowledge and experience reveals a need to increase ACP awareness. Differences in ACP preferences between patients and their caregivers may indicate the need for improved communication strategies by healthcare professionals. Further research is needed to understand these differences.</p>\",\"PeriodicalId\":19234,\"journal\":{\"name\":\"Neuro-oncology practice\",\"volume\":\"12 4\",\"pages\":\"732-742\"},\"PeriodicalIF\":2.5000,\"publicationDate\":\"2025-01-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12349760/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Neuro-oncology practice\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1093/nop/npaf008\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/8/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neuro-oncology practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/nop/npaf008","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/8/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
摘要
背景:预先护理计划(Advance care planning, ACP)可以帮助原发性恶性脑肿瘤患者根据自己的喜好选择治疗方案。然而,对患者和护理人员参与ACP的了解仍然很少。本研究详细阐述了他们在ACP方面的知识、经验和偏好。方法:这是对日本“全国脑肿瘤患者和护理人员需求和支持调查”数据的二次分析。来自128名患者和106名护理人员的回答被纳入研究。对自由文本回复进行描述性统计、逻辑回归和定性分析。结果:患者比护理人员更愿意参与治疗决策(96.8%比82.5%,P P P = 0.0019)。结论:被调查者参与ACP的意愿与他们的知识和经验之间的不匹配表明需要提高ACP意识。患者和护理者之间ACP偏好的差异可能表明医疗保健专业人员需要改进沟通策略。需要进一步的研究来理解这些差异。
Advance care planning in primary malignant brain tumors: Knowledge, experiences, and preferences of patients and caregivers.
Background: Advance care planning (ACP) can help patients with primary malignant brain tumors to align treatments with their preferences. However, insights into patients' and caregivers' engagement with ACP remain scarce. This study elaborates on their knowledge, experiences, and preferences concerning ACP.
Methods: This was a secondary analysis of data from the "National Survey on the Needs and Support of Brain Tumor Patients and Caregivers" in Japan. Responses from 128 patients and 106 caregivers were included. Descriptive statistics, logistic regression, and qualitative analyses of free-text responses were performed.
Results: Patients were more willing than caregivers to participate in decisions regarding their treatment (96.8% vs. 82.5%, P < .001). Knowledge about ACP was low in both groups (12.3% of patients and 10.7% of caregivers), but willingness to participate in ACP was high (68.9% of patients and 65.9% of caregivers). Preference to initiate ACP at diagnosis was low in both groups, with caregivers showing a higher preference than patients (29.0% vs. 11.1%). A greater percentage of patients preferred to start ACP at recurrence than caregivers (47.0% vs. 18.3%, P < .0001). Frequent family discussions were significantly associated with actual experiences of ACP (OR = 3.7, 95% CI = 1.6-9.3, P = .0019).
Conclusions: The mismatch between respondents' willingness to participate in ACP and their knowledge and experience reveals a need to increase ACP awareness. Differences in ACP preferences between patients and their caregivers may indicate the need for improved communication strategies by healthcare professionals. Further research is needed to understand these differences.
期刊介绍:
Neuro-Oncology Practice focuses on the clinical aspects of the subspecialty for practicing clinicians and healthcare specialists from a variety of disciplines including physicians, nurses, physical/occupational therapists, neuropsychologists, and palliative care specialists, who have focused their careers on clinical patient care and who want to apply the latest treatment advances to their practice. These include: Applying new trial results to improve standards of patient care Translating scientific advances such as tumor molecular profiling and advanced imaging into clinical treatment decision making and personalized brain tumor therapies Raising awareness of basic, translational and clinical research in areas of symptom management, survivorship, neurocognitive function, end of life issues and caregiving